Analyst Activity – Deutsche Bank AG Initiates Coverage On Core Laboratories N.V. (NYSE:CLB) With a Buy

ME Staff

7 years ago

Analyst Ratings For Core Laboratories N.V. (NYSE:CLB)

Today, Deutsche Bank AG initiated coverage on Core Laboratories N.V. (NYSE:CLB) with a Buy.

There are 1 sell rating, 7 hold ratings, 5 buy ratings on the stock.

The current consensus rating on Core Laboratories N.V. (NYSE:CLB) is Hold (Score: 2.31) with a consensus target price of $111.22 per share, a potential 16.07% upside.

Some recent analyst ratings include

10/10/2017-Deutsche Bank AG initiated coverage with a Buy rating.
8/24/2017-Credit Suisse Group Upgrade from a “Neutral ” rating to a ” Outperform” rating.

Dividend information for Core Laboratories N.V. (NYSE:CLB)

Core Laboratories N.V. (NYSE:CLB) pays an annual dividend of Community Ranking: with a yield of 2.30% and an average dividend growth of 19.80% based on a 3 Year Average.

Dividend History for Core Laboratories N.V. (NYSE:CLB)

On 7/6/2017 Core Laboratories N.V. announced a Quarterly dividend of $0.55 2.11% with an ex dividend date of 7/13/2017 which will be payable on 8/14/2017.
On 4/19/2017 Core Laboratories N.V. announced a quarterly dividend of $0.55 1.98% with an ex dividend date of 4/27/2017 which will be payable on 5/23/2017.
On 1/10/2017 Core Laboratories N.V. announced a Quarterly dividend of $0.55 1.8% with an ex dividend date of 1/18/2017 which will be payable on 2/17/2017.
On 10/11/2016 Core Laboratories N.V. announced a Quarterly dividend of $0.55 1.95% with an ex dividend date of 10/19/2016 which will be payable on 11/22/2016.
On 7/7/2016 Core Laboratories N.V. announced a Quarterly dividend of $0.55 with an ex dividend date of 7/14/2016 which will be payable on 8/15/2016.
On 4/15/2016 Core Laboratories N.V. announced a Quarterly dividend of $0.55 with an ex dividend date of 5/2/2016 which will be payable on 5/24/2016.
On 1/11/2016 Core Laboratories N.V. announced a Quarterly dividend of $0.55 2.28% with an ex dividend date of 1/20/2016 which will be payable on 2/19/2016.

On 2/1/2017 Michael Straughen, Director, bought 106 with an average share price of $118.65 per share and the total transaction amounting to $12,576.90. View SEC Filing
On 1/30/2017 Martha Z Carnes, Director, bought 200 with an average share price of $115.20 per share and the total transaction amounting to $23,040.00. View SEC Filing
On 2/2/2016 Jan Willem Sodderland, Director, bought 300 with an average share price of $93.90 per share and the total transaction amounting to $28,170.00. View SEC Filing
On 5/12/2015 Michael C Kearney, Director, sold 1,000 with an average share price of $128.52 per share and the total transaction amounting to $128,520.00. View SEC Filing
On 11/17/2014 Mark F Elvig, VP, sold 1,000 with an average share price of $138.03 per share and the total transaction amounting to $138,030.00. View SEC Filing
On 7/28/2014 Richard L Bergmark, CFO, bought 7,000 with an average share price of $147.31 per share and the total transaction amounting to $1,031,170.00. View SEC Filing
On 3/7/2014 Michael Kearney, Director, sold 2,000 with an average share price of $193.00 per share and the total transaction amounting to $386,000.00. View SEC Filing

Recent Trading Activity for Core Laboratories N.V. (NYSE:CLB)
Shares of Core Laboratories N.V. closed the previous trading session at with shares trading hands.